YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

J&J forecasts $2.5B in 2021 COVID-19 vaccine revenue

Posted online

Johnson & Johnson is predicting $2.5 billion in sales this year for its COVID-19 vaccine.

The company expects to produce up to 600 million doses of the one-shot vaccine this year. The previous goal was 1 billion shots.

The shot has faced production issues at a Baltimore plant run by J&J subcontractor Emergent BioSolutions Inc. Production was shut down after the U.S. Food and Drug Administration found sanitary problems and bad manufacturing practices, according to Reuters.

Read more from Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Home construction companies merge to launch new venture

Alair Springfield is first Missouri franchise for Canada-based company.

Most Read
Update cookies preferences